Valproate Metabolites and Hyperammonemia
References
- Kondo T Ishida M Kaneko S Hirano T Otani K Fukushima Y Is 2-propyl-4-pentonoic acid (4-en), a hepatotoxic metabolite of valproate, responsible for valproateinduced hyperammonemia? Epilepsia 1992 May-Jun 33 3 550 554 10.1111/j.1528-1157.1992.tb01708.x 1350534
- Kaji M Ito M Okuno T Momoi T Sasaki H Yamanaka C Serum copper and zinc levels in epileptic children with valproate treatment Epilepsia 1992 May-Jun 33 3 555 557 10.1111/j.1528-1157.1992.tb01709.x 1592036
- Pappo AS Fields BW Buchanan GR Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies Pediatrics 1992 Jun 89 6 Pt 1 1063 1067 1534402
DOI: https://doi.org/10.15844/pedneurbriefs-6-7-7 | Journal eISSN: 2166-6482
Language: English
Page range: 53 - 53
Published on: Jul 1, 1992
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1992 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.